CN113292454B - AIE molecule with cinnamonitrile as framework structure and preparation method and application thereof - Google Patents
AIE molecule with cinnamonitrile as framework structure and preparation method and application thereof Download PDFInfo
- Publication number
- CN113292454B CN113292454B CN202110621244.1A CN202110621244A CN113292454B CN 113292454 B CN113292454 B CN 113292454B CN 202110621244 A CN202110621244 A CN 202110621244A CN 113292454 B CN113292454 B CN 113292454B
- Authority
- CN
- China
- Prior art keywords
- chiral
- cinnamonitrile
- compound
- aie
- aie molecule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- ZWKNLRXFUTWSOY-QPJJXVBHSA-N (e)-3-phenylprop-2-enenitrile Chemical compound N#C\C=C\C1=CC=CC=C1 ZWKNLRXFUTWSOY-QPJJXVBHSA-N 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title description 10
- 239000000463 material Substances 0.000 claims abstract description 22
- 150000001875 compounds Chemical class 0.000 claims description 28
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 claims description 5
- 229930028154 D-arginine Natural products 0.000 claims description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 5
- 229930064664 L-arginine Natural products 0.000 claims description 5
- 235000014852 L-arginine Nutrition 0.000 claims description 5
- 230000000007 visual effect Effects 0.000 claims 1
- 230000002776 aggregation Effects 0.000 abstract description 8
- 238000004220 aggregation Methods 0.000 abstract description 8
- 238000005557 chiral recognition Methods 0.000 abstract description 7
- 235000001014 amino acid Nutrition 0.000 abstract description 5
- 150000001413 amino acids Chemical class 0.000 abstract description 5
- 238000011161 development Methods 0.000 abstract description 5
- -1 hexafluorophosphate Chemical compound 0.000 abstract description 5
- 230000004048 modification Effects 0.000 abstract description 5
- 238000012986 modification Methods 0.000 abstract description 5
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract description 3
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract description 3
- 235000004279 alanine Nutrition 0.000 abstract description 3
- 238000013461 design Methods 0.000 abstract description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract description 3
- 125000000524 functional group Chemical group 0.000 abstract 3
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 abstract 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 abstract 2
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000029936 alkylation Effects 0.000 abstract 1
- 238000005804 alkylation reaction Methods 0.000 abstract 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-M bromate Inorganic materials [O-]Br(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-M 0.000 abstract 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 abstract 1
- 239000001273 butane Substances 0.000 abstract 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 abstract 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 abstract 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 abstract 1
- 239000001294 propane Substances 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 17
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 239000002904 solvent Substances 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000004020 luminiscence type Methods 0.000 description 5
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 5
- 230000000171 quenching effect Effects 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 239000004475 Arginine Substances 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 235000009697 arginine Nutrition 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical group 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QVHJQCGUWFKTSE-RXMQYKEDSA-N (2r)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound OC(=O)[C@@H](C)NC(=O)OC(C)(C)C QVHJQCGUWFKTSE-RXMQYKEDSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- 238000010668 complexation reaction Methods 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000010287 polarization Effects 0.000 description 3
- QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 2
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 2
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 2
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 2
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 2
- PXNJGLAVKOXITN-UHFFFAOYSA-N 2-(4-nitrophenyl)acetonitrile Chemical compound [O-][N+](=O)C1=CC=C(CC#N)C=C1 PXNJGLAVKOXITN-UHFFFAOYSA-N 0.000 description 2
- NPRYCHLHHVWLQZ-TURQNECASA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one Chemical compound NC1=NC=C2N(C(N(C2=N1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C NPRYCHLHHVWLQZ-TURQNECASA-N 0.000 description 2
- KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 description 2
- UTNSTTZHNMPBEE-UHFFFAOYSA-N 2-chloro-2-hydroxy-2-phenylacetic acid Chemical compound OC(=O)C(O)(Cl)C1=CC=CC=C1 UTNSTTZHNMPBEE-UHFFFAOYSA-N 0.000 description 2
- BQQLXOLHHSGZNV-UHFFFAOYSA-N 3-amino-2-methyl-4-nitrophenol Chemical compound [N+](=O)([O-])C=1C(=C(C(=CC1)O)C)N BQQLXOLHHSGZNV-UHFFFAOYSA-N 0.000 description 2
- XFVZSRRZZNLWBW-UHFFFAOYSA-N 4-(Diethylamino)salicylaldehyde Chemical compound CCN(CC)C1=CC=C(C=O)C(O)=C1 XFVZSRRZZNLWBW-UHFFFAOYSA-N 0.000 description 2
- ZRYZBQLXDKPBDU-UHFFFAOYSA-N 4-bromobenzaldehyde Chemical compound BrC1=CC=C(C=O)C=C1 ZRYZBQLXDKPBDU-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 2
- 229940126639 Compound 33 Drugs 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- USPFMEKVPDBMCG-LBPRGKRZSA-N N-benzyloxycarbonyl-L-leucine Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)OCC1=CC=CC=C1 USPFMEKVPDBMCG-LBPRGKRZSA-N 0.000 description 2
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- ODHCTXKNWHHXJC-GSVOUGTGSA-N Pyroglutamic acid Natural products OC(=O)[C@H]1CCC(=O)N1 ODHCTXKNWHHXJC-GSVOUGTGSA-N 0.000 description 2
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 2
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 2
- ODHCTXKNWHHXJC-UHFFFAOYSA-N acide pyroglutamique Natural products OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940125877 compound 31 Drugs 0.000 description 2
- 229940125878 compound 36 Drugs 0.000 description 2
- 229940125807 compound 37 Drugs 0.000 description 2
- 229940127573 compound 38 Drugs 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 235000005772 leucine Nutrition 0.000 description 2
- 229960002510 mandelic acid Drugs 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 2
- 229960002009 naproxen Drugs 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Chemical group COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 2
- 238000001338 self-assembly Methods 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000002520 smart material Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000001119 stannous chloride Substances 0.000 description 2
- 235000011150 stannous chloride Nutrition 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- JLZUZNKTTIRERF-UHFFFAOYSA-N tetraphenylethylene Chemical compound C1=CC=CC=C1C(C=1C=CC=CC=1)=C(C=1C=CC=CC=1)C1=CC=CC=C1 JLZUZNKTTIRERF-UHFFFAOYSA-N 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- FHUDAMLDXFJHJE-UHFFFAOYSA-N 1,1,1-trifluoropropan-2-one Chemical compound CC(=O)C(F)(F)F FHUDAMLDXFJHJE-UHFFFAOYSA-N 0.000 description 1
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 1
- OQOLNSMRZSCCFZ-FLFKKZLDSA-N 9,10-bis[(e)-2-phenylethenyl]anthracene Chemical compound C=1C=CC=CC=1/C=C/C(C1=CC=CC=C11)=C2C=CC=CC2=C1\C=C\C1=CC=CC=C1 OQOLNSMRZSCCFZ-FLFKKZLDSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- NUGPIZCTELGDOS-QHCPKHFHSA-N N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclopentanecarboxamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CC[C@@H](C=1C=NC=CC=1)NC(=O)C1CCCC1)C NUGPIZCTELGDOS-QHCPKHFHSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000011914 asymmetric synthesis Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005281 excited state Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 description 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000329 molecular dynamics simulation Methods 0.000 description 1
- ITAXPEPPDQPUFE-RNFRBKRXSA-N n-[(1r,2r)-2-aminocyclohexyl]-2-chloroacetamide Chemical compound N[C@@H]1CCCC[C@H]1NC(=O)CCl ITAXPEPPDQPUFE-RNFRBKRXSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011540 sensing material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/35—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
- C07C255/36—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/24—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1011—Condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1014—Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1044—Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Materials Engineering (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention designs and develops a series of aggregation-induced emission molecules with cinnamonitrile structures, and can carry out a series of photophysical property modification and application development through functional modification of different groups on the same skeleton structure. Chiral functional groups include chiral amino acids such as alanine, leucine, serine, phenylalanine, and the like; the alkylation functional group comprises an alkyl chain structure such as methane, ethane, propane, butane and the like; the ionizing functional groups include iodate, bromate, hexafluorophosphate, and the like. The molecular platform has a large modification space and application prospect based on a unique structure, and has great potential in the fields of supermolecule assembly, chiral recognition, circularly polarized luminescent materials and the like.
Description
Technical Field
The invention belongs to the technical field of chiral molecules, relates to a chiral AIE molecule for a fluorescent probe, and in particular relates to an AIE molecule taking cinnamonitrile as a framework structure, and a preparation method and application thereof.
Background
In recent years, although research on chiral compounds (such as amino acids) has been greatly progressed, it is not difficult to find out that efficient, various environmentally-adaptive and biocompatible recognition probes are always lacking for recognition and quantitative analysis of chiral amino acids. Therefore, it is highly desirable to introduce a biological probe with unique aggregation-induced emission (AIE) characteristics, and to make up for the short plate in the research field by means of method innovation and a large number of attempts, and to enrich the application of the aggregation-induced emission material.
Circular Polarized Light (CPL) refers to a phenomenon in which a chiral luminescent material is excited to emit left-handed or right-handed circularly polarized light. The material with circular polarization luminescence property has important application in the aspects of 3D display, optical storage, optical anti-counterfeiting, asymmetric synthesis and the like. In the traditional method for improving the circular polarization luminescence asymmetry of small organic molecules, the self-assembly of molecules is an effective means, but for some molecules with aggregated luminescence quenching property, the method can limit the luminescence efficiency of the material at the same time. In order to solve the problem, luminescent molecules with unique AIE characteristics are introduced in the self-assembly process, so that the problems caused by aggregation luminescence quenching are expected to be solved structurally, and the structural selection and application development of the circularly polarized luminescent material are enriched.
Supramolecular materials have been widely used in a variety of applications including smart materials, drug delivery systems, surfactants, and the like. Chiral supermolecules generated by molecular dynamics or asymmetric stacking of macromolecules have the characteristics of dynamic stimulus response and amplification of chiral signals, and are therefore one of the most promising chiral materials.
Conventional fluorescent dye molecules undergo pi-pi stacking in an aggregated state to cause fluorescence quenching (ACQ), which limits development and application of fluorescent materials to a great extent. In 2001, an aggregation-induced emission (AIE) phenomenon was discovered and reported by the Tang Benzhong institute subject group, and molecules having AIE properties such as tetraphenyl ethylene (TPE) and 9, 10-distyryl anthracene (DSA) have a propeller type molecular structure, and a fluorescence enhancement phenomenon occurs due to limited rotation of benzene rings in an aggregated state. The AIE molecule breaks through the limitation of the aggregation quenching of the traditional fluorescent molecules, injects a new generator into the construction of functional fluorescent materials, especially solid fluorescent materials, and is a very original and advanced progress.
Among the existing AIE molecular research results, TPE has been the most popular and mature research methods and technological paths have been developed, and many applications have been developed. However, the number of documents using cinnamonitrile as a skeleton structure is small, the technical path is not mature, the development in application is less, and more scientific researchers need to put into a great deal of work for research. The present inventors have obtained the present invention by synthesizing and preparing a series of molecules having AIE activity, and detecting and studying their supermolecule assembly behavior by using host-guest effect.
Disclosure of Invention
The invention aims to overcome the defects, find out a high-efficiency mature research method, synthesize AIE molecules with advanced photophysical properties and using cinnamonitrile as a framework structure, develop application scenes with practicability and novelty, and provide a new thought and a new molecular platform for researching novel functional materials.
Based on the above object, the present invention provides an AIE molecule having a cinnamonitrile as a skeleton structure, which has a structure as shown in general formula (a):
in the formula (A), the substituent R1 is selected from one of nitro, amino, o-cresol, 4- (diethylamino) salicylaldehyde, alanine, arginine, leucine, N-carbobenzoxy-leucine, glutamic acid, mandelic acid, chloromandelic acid, serine, phenylalanine, tartaric acid, pyroglutamic acid, cysteine, dibenzoyltartaric acid, di-p-methylbenzotripropionic acid, naproxen (methyl isopropyl acid), valine, tryptophan, proline, methionine, aspartic acid, tyrosine and histidine;
the substituent R2 is selected from hydroxyl, halogen, pyridine or one of the formulas (B), (C) and (D);
in formula (B), the anion X is selected from PF 6 - ,I - ,Br - ,Cl - One of the following; n represents an integer of 0 or more;
the formula (C) is named as N- [ (1R, 2R) -2-aminocyclohexyl ] -2-chloroacetamide, and the formula (D) is named as N- [ (1S, 2S) -2-aminocyclohexyl ] -2-chloroacetamide, which are all chemical structures autonomously synthesized by the inventors.
Further, the halogen is selected from one of F, cl, br, I.
As a preferred embodiment of the present invention, the AIE molecule with cinnamonitrile as a skeleton structure comprises the chemical structures described in the compounds 1-30:
the invention also provides a preparation method of the AIE molecule taking cinnamonitrile as a framework structure, the raw material components for preparing the compounds 1-30 comprise a compound 31 and a compound 32,
specifically, taking the preparation method of the compound 9 as an example, the preparation route is as follows:
those of ordinary skill in the art know that AIE materials find use in almost any luminescent material field, such as smart materials that specifically respond to stimuli (pH, temperature, solvents, pressure, etc.) and reversibly sense, liquid crystal or polarized light materials of tunable refractive index, high efficiency OLED display and illumination materials, optical waveguide materials, selective biochemical sensing materials, trace recognition materials, and cellular organelles, viruses or bacteria in biological systems, vascular imaging materials, etc. The AIE molecule taking the cinnamonitrile as a framework structure provided by the invention is specifically characterized in that according to different fluorescence intensities after the AIE molecule is complexed with arginine with different chiralities, chiral compounds with isomerism such as L-arginine, D-arginine and the like can be visually identified according to the determination of the fluorescence intensities. In addition, the AIE molecules can also be applied to supramolecular assembly and circularly polarized luminescent materials.
Compared with the prior art, the invention has the following beneficial effects or advantages:
the molecular development scheme of the invention starts from a simple molecular structure, synthesizes a precursor compound of the AIE chiral fluorescent probe, synthesizes the designed chiral recognition fluorescent probe through different group modification, and finally separates to obtain a high-purity target product. Cinnamonitrile molecules with AIE properties are less common than traditional chiral molecules, and the invention designs unique molecular structures, which can affect chiral signals and CPL signals through supermolecular assembly effects, which is more rare. Taking chiral recognition as an example, through the experiment of the inventor, in the chiral recognition test, obvious fluorescence difference can be observed through a fluorescence test, and a pair of chiral amino acids can be accurately recognized through complexation, so that the AIE molecule with the cinnamonitrile as a framework structure can be accurately and visually recognized.
Drawings
FIG. 1 is a graph of AIE curve test results for Compound 9.
FIG. 2 is a plot of the fluorescence intensity ratio of Compound 9 at various percentages of poor solvent (THF).
Fig. 3 is a graph showing a change in fluorescence spectrum of 39= [ L-arginine ] = (5.0×10-4M), 40= [ D-arginine ] = (5.0×10-4M) in water to which THF was added.
FIG. 4 shows the application of AIE molecules with unique cinnamonitrile structure in chiral recognition and assembly of circular polarized luminescent material and supermolecule.
FIG. 5 is a simulated configuration of supramolecular assembly of compound 3 with cyclodextrin.
Fig. 6 is a schematic diagram of CD signals in a CPL test.
Detailed Description
The following describes embodiments of the present invention with reference to the drawings and specific embodiments, but the present invention is not limited to the following embodiments.
An AIE molecule having a cinnamonitrile skeleton structure, which has a structure represented by formula (a):
in the formula (A), the substituent R1 is selected from one of nitro, amino, o-cresol, 4- (diethylamino) salicylaldehyde, alanine, arginine, leucine, N-carbobenzoxy-leucine, glutamic acid, mandelic acid, chloromandelic acid, serine, phenylalanine, tartaric acid, pyroglutamic acid, cysteine, dibenzoyltartaric acid, di-p-methylbenzotripropionic acid, naproxen (methyl isopropyl acid), valine, tryptophan, proline, methionine, aspartic acid, tyrosine and histidine;
the substituent R2 is selected from hydroxyl, halogen, pyridine or one of the formulas (B), (C) and (D);
in formula (B), the anion X is selected from PF 6 - ,I - ,Br - ,Cl - One of the following; n represents an integer of 0 or more.
Wherein the halogen is selected from one of F, cl, br, I.
As a preferred embodiment of the present invention, the AIE molecule with cinnamonitrile as a skeleton structure comprises the chemical structures described in the compounds 1-30:
/>
/>
/>
/>
the invention also provides a preparation method of the AIE molecule taking cinnamonitrile as a framework structure, which comprises the following main raw material compounds,
specifically, taking the preparation method of the compound 9 as an example, the preparation method comprises the following steps:
the raw material components thereof include, in addition to the essential main raw material compounds 31 and 32 described above: p-nitrophenylacetonitrile (CAS: 555-21-5), p-bromobenzaldehyde (CAS: 1122-91-4), pyridine-4-boronic acid (CAS: 1692-15-5), N- (tert-butoxycarbonyl) -D-alanine (CAS: 7764-95-6), triethylamine (CAS: 121-44-8), 1, 4-dioxane (CAS: 123-91-1), anhydrous potassium carbonate (CAS: 584-08-7), tetrakis (triphenylphosphine) palladium (CAS: 14221-01-3), stannous chloride (CAS: 7772-99-8), ethanol (CAS: 64-17-5), hydroxybenzotriazole (CAS: 2592-95-2), 1- (3-dimethylaminopropyl) -3-ethylcarbodiimide hydrochloride (CAS: 25952-53-8), tetrahydrofuran (CAS: 109-99-9), methyl iodide (CAS: 74-88-4), acetonitrile (CAS: 75-05-8), potassium hexafluorophosphate (CAS: 17084-13-8), methylene chloride (CAS: 64-17-5), and trifluoroacetone (CAS: 76-75-09-75).
Specifically, the preparation steps are as follows:
synthesis of Compound 33: in a 50ml round bottom flask was charged compound 31 (2.28 g,12.33 mmol), compound 32 (2 g,12.33 mmol), 1, 4-dioxane 30ml,3ml triethylamine, and the reaction was stirred at ambient temperature and pressure to give a yellowish green precipitate. The reaction was checked by TLC (ethyl acetate: petroleum ether=1:2 as developing reagent) and stopped after two days. Filtering to obtain yellow-green solid. 3.49g of product are obtained, 4.05g of theoretical yield and 86% of yield.
Synthesis of Compound 34: a250 ml two-necked round bottom flask was charged with compound 33 (2 g,6 mmol), pyridine-4-boronic acid (1.5 g,12 mmol), anhydrous potassium carbonate (4 g,30 mmol) and tetrakis (triphenylphosphine) palladium (0.35 g,0.3 mmol) in an ice bath. Three cycles of evacuating the flask and changing nitrogen were performed, the solvent (96 ml, tetrahydrofuran: water=5:1) was added by syringe, the ice bath was removed, and the reaction was stirred at 80 ℃ under reflux. The reaction was checked by TLC (ethyl acetate: petroleum ether=1:1 as developing reagent) and stopped after 12 hours. After spin-drying, the mixture was dissolved in methylene chloride, extracted three times with water, and dried over anhydrous sodium sulfate. Purifying by column chromatography to obtain yellow green solid. 1.36g of product was obtained in a theoretical yield of 1.96g and a yield of 69%.
Synthesis of Compound 35: a50 ml round bottom flask was charged with compound 34 (1.36 g,4.16 mmol), stannous chloride (3.94 g,20.8 mmol), 22ml ethanol and the reaction was stirred at 95℃under reflux. The reaction was checked by TLC (ethyl acetate: petroleum ether=2:1 as developing reagent) and stopped after 6 hours. The pH was adjusted to 8-9 with sodium bicarbonate (solution changed from red to golden yellow), the solvent was dried with spin-on, dissolved with ethyl acetate, extracted three times with water, the organic phases combined and dried over anhydrous sodium sulfate. Purifying by column chromatography to obtain yellow solid. 1.16g of product was obtained, 1.23g of theoretical yield and 94% of yield.
Synthesis of Compound 36: a50 ml two-necked round bottom flask was charged with 35 (0.71 g,2.3 mmol) of the compound, BOC-D-alanine (1.8 g,9.2 mmol), 1-hydroxybenzotriazole (0.13 g,0.92 mmol) and 1- (3-dimethylaminopropyl) -3-ethyl-carbodiimide hydrochloride (1.31 g,6.9 mmol), and the flask was evacuated and purged with nitrogen three cycles, fresh anhydrous tetrahydrofuran (18 ml) was added by syringe, and the reaction was stirred at 85℃under reflux. The reaction was checked by TLC (ethyl acetate: petroleum ether=1:1 as developing reagent) and stopped after 12 hours. Adjusting pH to 8-9 with sodium bicarbonate, and purifying by column chromatography to obtain yellow solid. 0.875g of product was obtained, 1.07g of theoretical yield and 81% yield.
Synthesis of Compound 37: a50 ml round bottom flask was charged with compound 36 (0.264 g,0.576 mmol), methyl iodide (0.537 ml,8.64 mmol), 15ml acetonitrile and the reaction was stirred at 90℃under reflux. The reaction was checked by TLC (developing solvent dichloromethane: methanol=5:1), after 8 hours, the reaction was stopped and the spin-dried solvent was directly added to the next reaction.
Synthesis of Compound 38: in a flask of the spin-dried compound 37 was added acetone 15ml, potassium hexafluorophosphate (2 ml,14.25 mmol), and the reaction was stirred at 65℃under reflux. TLC detection reaction (developing solvent dichloromethane: methanol=5:1) was performed after 8 hours, and after completion of the reaction, the reaction was stopped and purified by column chromatography to give a yellow solid. 0.254g of product was obtained, 0.278g of theoretical yield and 91.3% yield.
Synthesis of compound 9: a50 ml round bottom flask was charged with compound 38 (0.29 g,0.6 mmol), trifluoroacetic acid (2.5 ml,30 mmol), dichloromethane (10 ml) and the reaction was stirred at ambient temperature and pressure. After 8 hours, the reaction was stopped. The spin-dry solvent is dried by sodium bicarbonate until the pH value is 8-9, and a water-soluble yellow solid is obtained. 0.217g of product was obtained in a theoretical yield of 0.229g and a yield of 94%.
1. The aggregation-induced emission effect fluorescence test of the compound 9 comprises the following specific steps:
(1) Compound 9 prepared according to the present invention was formulated as c 1 =1×10 -3 3ml of a mol/L target molecule solution;
(2) Taking c 1 0.5ml of solution, constant volume c 2 =1×10 -4 mol/L to 5ml;
(3) Wherein the ratio of the poor solvent is 0%,10%,20%,30%,40%,50%,60%,70%,80%,90%,95%,99%, respectively, and fluorescence test is performed.
2. The chiral recognition fluorescence test of the compound 9 comprises the following specific steps:
(1) Compound 9 prepared according to the present invention was formulated as c 1 =1×10 -4 Taking 3mL of a target molecule solution with mol/L, and adding the target molecule solution into a quartz tube;
(2) The L-arginine and the D-arginine are respectively prepared into 5 multiplied by 10 -2 30 mu L of each of the solutions was put into a quartz tube;
(3) To the vial was added 500 μl of poor solvent THF and tested for fluorescence intensity;
(4) Each 500. Mu.L of poor solvent THF was added until the ratio of the poor solvent THF was 99%, and the change in fluorescence intensity and the difference in fluorescence intensity of Compound 9 after complexation with two amino acids were measured.
It can be seen from fig. 1 and 2 that compound 9 belongs to D-a type molecules, and fluorescence quenching in solution is mainly caused by the transition from a Local Excited (LE) state with high luminous efficiency to a tic state with low luminous efficiency; while in the aggregated state, transition from the local excited state to the tic state is prevented, so that the AIE phenomenon occurs.
From FIG. 3, it is clear that L-arginine and D-arginine can be identified based on the difference in fluorescence intensity after complexation of compound 9 with arginine of different chiralities, so that it can be determined that this strategy is feasible for use in the identification of chiral compounds.
As shown in figure 4, the AIE molecule with unique cinnamonitrile structure designed by the invention can be further applied and photophysical property modified on chiral recognition, circular polarization luminescent material and supermolecule assembly strategy, and is a molecular platform with great potential.
In addition, the cinnamonitrile structure compound (exemplified as compound 3) having J aggregation property can be host-guest assembled with a common host compound such as γ -CD (γ -cyclodextrin), and fig. 5 is a simulated configuration of supermolecule assembly of the compound 3 of the present invention with cyclodextrin.
Because the chiral AIE compounds developed in the present invention have chiral groups, a pair of compounds that are chiral to each other should have equal and opposite CPL signals, and fig. 6 is a schematic of CD signals in the CPL test of the compounds of the present invention.
The present invention may be better implemented as described above, and the above examples are merely illustrative of preferred embodiments of the present invention and not intended to limit the scope of the present invention, and various changes and modifications made by those skilled in the art to the technical solution of the present invention should fall within the scope of protection defined by the present invention without departing from the spirit of the design of the present invention.
Claims (4)
1. An AIE molecule taking cinnamonitrile as a framework structure, which is characterized in that the structural formula of the AIE molecule is shown as a compound 9:
。
2. use of the AIE molecule according to claim 1 for visual recognition of chiral compounds, said chiral compounds being L-arginine or D-arginine.
3. Use of the AIE molecule of claim 1 in supramolecular assembly.
4. Use of the AIE molecule of claim 1 in a circularly polarized luminescent material.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110621244.1A CN113292454B (en) | 2021-06-03 | 2021-06-03 | AIE molecule with cinnamonitrile as framework structure and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110621244.1A CN113292454B (en) | 2021-06-03 | 2021-06-03 | AIE molecule with cinnamonitrile as framework structure and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113292454A CN113292454A (en) | 2021-08-24 |
CN113292454B true CN113292454B (en) | 2023-11-24 |
Family
ID=77327038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110621244.1A Active CN113292454B (en) | 2021-06-03 | 2021-06-03 | AIE molecule with cinnamonitrile as framework structure and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113292454B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016196447A (en) * | 2015-03-11 | 2016-11-24 | 国立大学法人九州大学 | Fluorescent compound or salt thereof, agent of detecting ionic compound and method of detecting ionic compound |
CN110240699A (en) * | 2019-06-14 | 2019-09-17 | 湘潭大学 | One kind has the side chain liquid crystalline polymer and preparation method thereof of circular polarised luminescence performance |
-
2021
- 2021-06-03 CN CN202110621244.1A patent/CN113292454B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016196447A (en) * | 2015-03-11 | 2016-11-24 | 国立大学法人九州大学 | Fluorescent compound or salt thereof, agent of detecting ionic compound and method of detecting ionic compound |
CN110240699A (en) * | 2019-06-14 | 2019-09-17 | 湘潭大学 | One kind has the side chain liquid crystalline polymer and preparation method thereof of circular polarised luminescence performance |
Non-Patent Citations (4)
Title |
---|
CAS:50632-41-2等.STN数据库结构检索获得.2018,第1-4页. * |
Dong-Mi Li,et al.Highly enantioselective recognition of a wide range of carboxylic acids based on enantioselectively aggregation-induced emission.《Chemical Communications》.2011,第47卷第10139-10141页. * |
Hongxing Shang,et al..Multi-color tunable circularly polarized luminescence in one single AIE system.《Chemical Science》.2020,第11卷(第8期),第2169-2174页. * |
Jiabin Qiu,et al.An unusual AIE fluorescent sensor for sequentially detecting Co2+-Hg2+-Cu2+ based on diphenylacrylonitrile Schiff-base derivative.《Dyes and Pigments》.2019,第170卷第107590页. * |
Also Published As
Publication number | Publication date |
---|---|
CN113292454A (en) | 2021-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108070092B (en) | Supermolecular gel based on functionalized column [5] arene and application thereof in identifying iron ions and L-Cys | |
Chen et al. | Novel diisocyano-based dinuclear gold (I) complexes with aggregation-induced emission and mechanochromism characteristics | |
Li et al. | Circularly polarized luminescence and controllable helical self-assembly of an aggregation-induced emission luminogen | |
Sun et al. | Structure-property relationship on aggregation-induced emission properties of simple azine-based AIEgens and its application in metal ions detection | |
Gong et al. | First stable (Z)-configuration of cyanostilbene derivative: An effective “turn-on “fluorescent sensor for lysine in aqueous media | |
Zhu et al. | Modulation of ICT and PET processes in boranil derivatives: a ratiometric fluorescent probe for imaging of cysteine | |
Chen et al. | Synthesis and studies of axial chiral bisbenzocoumarins: Aggregation-induced emission enhancement properties and aggregation-annihilation circular dichroism effects | |
CN107759504B (en) | Dual-phase organic fluorescent material with strong fluorescence in solid and liquid states and preparation method thereof | |
CN103409134B (en) | Bifluorescence-emission organic light-emitting material and preparation method thereof | |
CN104356055B (en) | A kind of dihydrogen pyridine derivatives and synthetic method thereof and purposes | |
Yang et al. | Novel flavonoid derivatives and their corresponding rare earth complexes: Synthesis and luminescent properties | |
CN113292454B (en) | AIE molecule with cinnamonitrile as framework structure and preparation method and application thereof | |
CN113387905A (en) | Organic room temperature phosphorescent material, preparation method and application | |
CN105837568B (en) | A kind of fluorenyl β carbolines class compound, its application and preparation method as luminous organic material and aggregation inducing Fluorescence Increasing material | |
CN112851556A (en) | Novel aggregation-induced emission Golgi fluorescence probe and preparation method and application thereof | |
CN114853656B (en) | Carbazole derivative with AEE characteristic, preparation method and application | |
Zhang et al. | Three-arm star-shaped aniline derivatives: Tunable photoluminescence, aggregation-induced emission and reversible acid-base vapor fluorescence response | |
CN112341462A (en) | Rare earth dysprosium cryptate ether fluorescent complex and preparation method thereof | |
Chen et al. | Turn-on circularly polarized luminescence for dynamical-racemic and large-hollow AIE macrocycle based on selective recognition for ursolic acid | |
Aparicio et al. | A pyrene-functionalized foldamer: structural impact and recognition properties supported by donor–acceptor interactions | |
Ooyama et al. | Photophysical properties and photostability of novel symmetric polycyclicphenazine-type fluorescent dyes and the dye-doped films | |
CN112920095B (en) | Novel aggregation-induced emission endoplasmic reticulum fluorescent probe and preparation method and application thereof | |
CN112174988B (en) | Tertiary rare earth terbium trimer and its preparation method | |
CN110862420B (en) | Energy transfer luminescent material based on triplet donor material and acceptor material and application thereof | |
CN114773875A (en) | Azaindole-squarylium cyanine dye, and synthesis method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |